What Is Retatrutide?

Retatrutide (also known by its investigational designation LY3437943) is a groundbreaking peptide that represents the next evolution in metabolic medicine. Unlike any currently FDA-approved weight loss medication, Retatrutide is a triple agonist — meaning it simultaneously activates three distinct hormone receptor systems involved in weight regulation and metabolic control:

  • GLP-1 receptors (glucagon-like peptide-1) — suppresses appetite, slows gastric emptying, improves blood sugar
  • GIP receptors (glucose-dependent insulinotropic polypeptide) — enhances insulin response, improves fat metabolism
  • Glucagon receptors — directly increases energy expenditure, promotes fat breakdown in the liver

By targeting all three pathways together, Retatrutide produces synergistic metabolic effects that neither semaglutide (GLP-1 only) nor tirzepatide (GLP-1 + GIP) can match.

Why Retatrutide Is a Game-Changer

The clinical data for Retatrutide is extraordinary. Phase 2 trials published in the New England Journal of Medicine demonstrated:

  • Mean weight loss of 24.2% of body weight over 48 weeks at the highest dose
  • Up to 58% of participants achieved at least 20% weight loss
  • Significant improvements in blood pressure, cholesterol, and blood glucose
  • Results exceeding any currently FDA-approved medication for obesity

To put this in perspective: someone weighing 250 pounds could expect to lose approximately 60 pounds — a result previously achievable only through bariatric surgery.

The Triple Agonist Advantage

GLP-1: Appetite & Glucose Control

The GLP-1 component suppresses appetite centers in the brain, reduces cravings, slows digestion, and improves insulin secretion. This is the same mechanism behind semaglutide's success.

GIP: Enhanced Metabolic Response

GIP amplifies the insulin response in a glucose-dependent manner (reducing hypoglycemia risk) and appears to enhance fat metabolism in adipose tissue. The addition of GIP is why tirzepatide outperforms semaglutide.

Glucagon: Direct Fat Burning

The glucagon agonism is what makes Retatrutide truly unique. Glucagon directly increases energy expenditure, promotes hepatic fat oxidation (burning fat in the liver), and enhances whole-body metabolic rate. This third mechanism is why Retatrutide's results are superior to both predecessors.

Retatrutide at Kanvas Wellness, Hendersonville TN

Kanvas Wellness is proud to be one of the very few providers in Hendersonville and the greater Nashville area offering Retatrutide as part of our advanced metabolic therapy program. While most practices are still working with first or second-generation GLP-1 therapies, our specialist team stays at the forefront of peptide medicine — bringing our patients access to the most advanced treatments available.

Every Retatrutide protocol at Kanvas Wellness begins with a comprehensive medical evaluation. Our specialist team reviews your health history, metabolic labs, and goals before designing a personalized dosing protocol. Regular follow-up ensures safety, efficacy, and optimal dose titration.

Is Retatrutide Right for You?

Retatrutide may be appropriate for patients who:

  • Have had partial or plateau results with semaglutide or tirzepatide
  • Have significant weight loss goals (20%+ body weight reduction)
  • Have metabolic syndrome, type 2 diabetes, or fatty liver disease
  • Are seeking the most advanced, results-oriented approach available
  • Want access to a protocol not widely available in Middle Tennessee

Medical Disclaimer

Retatrutide is an investigational compound currently in Phase 3 clinical trials and not yet FDA-approved. It is available through licensed medical providers as part of compounded peptide protocols under strict medical supervision. Common side effects are similar to other GLP-1 class medications (nausea, GI effects during titration). All use at Kanvas Wellness requires a thorough medical evaluation and ongoing monitoring. Individual results vary. This does not constitute medical advice.